I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Wood, Nolan
503
results:
Search for persons
X
Format
Online (503)
Mediatypes
E-Books (2)
Articles (Online) (123)
Bookchapter (Online) (3)
OpenAccess-fulltext (375)
Sorted by: Relevance
Sorted by: Year
?
1
The use of quantitative clinical pharmacology approaches to..:
Wood, Nolan D.
;
Smith, Danelle
;
Kinrade, Sally A.
...
PLOS Neglected Tropical Diseases. 18 (2024) 8 - p. e0012351 , 2024
Link:
https://doi.org/10.1371/..
?
2
Safety and Pharmacokinetics of Single Ascending Doses of KN..:
OBrien, Christopher
;
Morgan, Frazer
;
Wood, Nolan
...
Journal of Allergy and Clinical Immunology. 153 (2024) 2 - p. AB142 , 2024
Link:
https://doi.org/10.1016/..
?
3
Population Pharmacokinetic Meta-Analysis to Bridge Ferumoxy..:
Plock, Nele
;
Facius, Axel
;
Lahu, Gezim
...
Clinical Pharmacokinetics. 54 (2014) 4 - p. 385-395 , 2014
Link:
https://doi.org/10.1007/..
?
4
Effects of Hepatic Dysfunction on the Single-Dose Pharmacok..:
de Mey, Christian
;
Mateva, Lyudmila
;
Krastev, Zahariy
...
The Journal of Clinical Pharmacology. 51 (2011) 3 - p. 397-405 , 2011
Link:
https://doi.org/10.1177/..
?
5
Evaluation of drug–drug interactions with fesoterodine:
Malhotra, Bimal
;
Sachse, Richard
;
Wood, Nolan
European Journal of Clinical Pharmacology. 65 (2009) 6 - p. 551-560 , 2009
Link:
https://doi.org/10.1007/..
?
6
Assessment of the Effects of Renal Impairment on the Pharma..:
Malhotra, Bimal
;
Gandelman, Kuan
;
Sachse, Richard
.
The Journal of Clinical Pharmacology. 49 (2009) 4 - p. 477-482 , 2009
Link:
https://doi.org/10.1177/..
?
7
Pharmacokinetics, Safety and Tolerance of Voriconazole in R..:
Abel, Samantha
;
Allan, Richard
;
Gandelman, Kuan
...
Clinical Drug Investigation. 28 (2008) 7 - p. 409-420 , 2008
Link:
https://doi.org/10.2165/..
?
8
Investigation of the Potential Relationships Between Plasma..:
Tan, Keith
;
Brayshaw, Nigel
;
Tomaszewski, Konrad
..
The Journal of Clinical Pharmacology. 46 (2006) 2 - p. 235-243 , 2006
Link:
https://doi.org/10.1177/..
?
9
The pharmacokinetics and safety of intravenous voriconazole..:
Purkins, Lynn
;
Wood, Nolan
;
Greenhalgh, Katie
...
British Journal of Clinical Pharmacology. 56 (2003) s1 - p. 2-9 , 2003
Link:
https://doi.org/10.1046/..
?
10
Voriconazole, a novel wide‐spectrum triazole: oral pharmaco..:
Purkins, Lynn
;
Wood, Nolan
;
Greenhalgh, Katie
..
British Journal of Clinical Pharmacology. 56 (2003) s1 - p. 10-16 , 2003
Link:
https://doi.org/10.1046/..
?
11
Safety of Voriconazole and Dose Individualization:
Lutsar, Irja
;
Hodges, Mike R.
;
Tomaszewski, Konrad
..
Clinical Infectious Diseases. 36 (2003) 8 - p. 1087-1088 , 2003
Link:
https://doi.org/10.1086/..
?
12
Histamine H2‐receptor antagonists have no clinically signif..:
Purkins, Lynn
;
Wood, Nolan
;
Kleinermans, Diane
.
British Journal of Clinical Pharmacology. 56 (2003) s1 - p. 51-55 , 2003
Link:
https://doi.org/10.1046/..
?
13
No clinically significant effect of erythromycin or azithro..:
Purkins, Lynn
;
Wood, Nolan
;
Ghahramani, Parviz
...
British Journal of Clinical Pharmacology. 56 (2003) s1 - p. 30-36 , 2003
Link:
https://doi.org/10.1046/..
?
14
Voriconazole potentiates warfarin‐induced prothrombin time ..:
Purkins, Lynn
;
Wood, Nolan
;
Kleinermans, Diane
.
British Journal of Clinical Pharmacology. 56 (2003) s1 - p. 24-29 , 2003
Link:
https://doi.org/10.1046/..
?
15
No clinically significant pharmacokinetic interactions betw..:
Purkins, Lynn
;
Wood, Nolan
;
Kleinermans, Diane
.
British Journal of Clinical Pharmacology. 56 (2003) s1 - p. 62-68 , 2003
Link:
https://doi.org/10.1046/..
1-15